Patents by Inventor Jill Caswell

Jill Caswell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-AREG/HB-EGF antibodies and treatment
    Patent number: 8846868
    Abstract: Described are cross-specific antibody molecules with binding specificity for both AREG and HBEGF. The antibody molecules may be used in methods of treatment of cancer and diseases associated with angiogenesis.
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: September 30, 2014
    Assignee: Fusion Antibodies Limited
    Inventors: Jill Caswell, Shane Olwill, James Johnston, Richard Buick, Thomas Jaquin, Declan Doherty, Christopher Scott
  • ANTI-AREG/HB-EGF ANTIBODIES AND TREATMENT
    Publication number: 20110150886
    Abstract: Described are cross-specific antibody molecules with binding specificity for both AREG and HBEGF. The antibody molecules may be used in methods of treatment of cancer and diseases associated with angiogenesis.
    Type: Application
    Filed: April 17, 2009
    Publication date: June 23, 2011
    Applicant: FUSION ANTIBODIES LIMITED
    Inventors: Jill Caswell, Shane Olwill, James Johnston, Richard Buick, Thomas Jaquin, Declan Doherty, Christopher Scott